Zusammenfassung
Die Erforschung der Apoptose hat eine lange Geschichte. Schon der römische Arzt und Schriftsteller Galenus Galen (129–199) beschrieb anhand des Foramen ovale des Herzens, dass sich larvale und fetale Strukturen im Zug der Ontogenese durch programmierten Zelltod zurückbilden (Barclay et al. 1944, Clarke u. Clarke 1996). Die erste derartige Arbeit der Neuzeit wird Vesalius (1564) zugeschrieben (Barclay et al. 1944). Im 17. und 18. Jahrhundert folgten dann zahlreiche Veröffentlichungen über den Umbau von Strukturen des Herzens (z. B. Haller 1758, Harvey 1628); und im frühen 19. Jahrhundert entdeckte Rathke (1825), dass sich auch in Säugetierfeten vorübergehend Kiemenbögen entwickeln. Eine detaillierte Beschreibung der Metamorphose der Kaulquappe lieferte Dugès bereits 1835.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adachi M, Watanabe-Fukunaga R, Nagata S (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of 1pr mice. Proc Natl Acad Sci USA 90: 1756–1760
Adachi M, Suematsu S, Kondo T et al. (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11: 294–300
Ahmad M, Srinivasula SM, Hegde R, Mukattash R, Fernandes-Alnemri T, Alnemri ES (1998) Identification and characterization of murine caspase-14, a new member of the caspase family. Cancer Res 58: 5201–5205
Alderson MR, Tough TW, Davis-Smith T et al. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181: 71–77
Allison J, Georgiou HM, Strasser A, Vaux DL (1997) Trans-genic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 94: 3943–3947
Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/ CED-3 protease nomenclature. Cell 87: 171
Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917–921
Anderson DM, Maraskovsky E, Billingsley WL et al. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175–179
Ando K, Guidotti LG, Wirth S et al. (1994) Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 152: 3245–3253
Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, Casciola-Rosen L (1998) Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 8: 451–460
Antonsson B, Conti F, Ciavatta A et al. (1997) Inhibition of Bax channel-forming activity by Bd-2. Science 277: 370–372
Arai H, Chan SY, Bishop DK, Nabel GJ (1997) Inhibition of the alloantibody response by CD95 ligand. Nat Med 3: 843–848
Armstrong RC, Aja T, Xiang J et al. (1996) Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bc1–2 and by ICE family protease inhibitors. J Biol Chem 271:16. 850–16. 855
Ashkenazi A, Pai RC, Fong S et al. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155–162
Baker SJ, Reddy EP (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12: 1–9
Banner DW, D’Arcy A, Janes W et al. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73: 431–445
Barclay AE, Franklin KJ, Prichard MML (1944) The fetal circulation and cardiovascular system and the changes they undergo at birth. Blackwell, Oxford
Bedossa P, Peltier E, Terris B, Franco D, Poynard T (1995) Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21: 760–766
Bennett MW, O’Connell J, O’Sullivan GC et al. (1998) The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 160: 5669–5675
Bennett MW, O’Connell J, O’Sullivan G et al. (1999) Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut 44: 156–162
Beresford PJ, Xia Z, Greenberg AH, Lieberman J (1999) Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation [published erratum appears in Immunity 1999 Jun; 10(6):following 768]. Immunity 10: 585–594
Bernard G, Breittmayer JP, Matteis M de, Trampont P, Hof-man P, Senik A, Bernard A (1997) Apoptosis of immature thymocytes mediated by E2/CD99. J Immunol 158: 25432550
Berndt C, Mopps B, Angermuller S, Gierschik P, Krammer PH (1998) CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells. Proc Natl Acad Sci USA 95:12 556–12 561
Beutler B, Huffel C van (1994) Unraveling function in the TNF ligand and receptor families. Science 264: 667–668
Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350–1358
Bodmer JL, Burns K, Schneider P et al. (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6: 79–88
Boehmer H von, Teh HS, Kisielow P (1989) The thymus selects the useful, neglects the useless and destroys the harmful. Immunol Today 10: 57–61
Boise LH, Thompson CB (1997) Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci USA 94: 3759–3764
Boise LH, Gonzalez-Garcia M, Postema CE et al. (1993) Mx, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597–608
Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803–815
Bouillet P, Metcalf D, Huang DC et al. (1999) Proapoptotic Bd-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735–1738
Browning JL, Ngam-ek A, Lawton P et al. (1993) Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72: 847–856
Brunner T, Mogil RJ, LaFace D et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441–444
Bulow GU von, Bram RJ (1997) NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278: 138–141
Camerini D, Walz G, Loenen WA, Borst J, Seed B (1991) The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol 147: 3165–3169
Cerretti DP, Hollingsworth LT, Kozlosky CJ et al. (1994) Molecular characterization of the gene for human interleukin-1 beta converting enzyme (IL1BC). Genomics 20: 468–473
Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288: 2351–2354
Charlotte F, L’Hermine A, Martin N et al. (1994) Immunohistochemical detection of bc1–2 protein in normal and pathological human liver. Am J Pathol 144: 460–465
Chen Z, Naito M, Hori S, Mashima T, Yamori T, Tsuruo T (1999) A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun 264: 847–854
Chen J, Wu W, Tahir SK et al. (2000) Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2: 235–241
Chicheportiche Y, Bourdon PR, Xu H et al. (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272: 3240132 410
Chinnaiyan AM, Dixit VM (1996) The cell-death machine. Curr Biol 6: 555–562
Chinnaiyan AM, O’Rourke K, Yu GL et al. (1996a) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990–992
Chinnaiyan AM, Orth K, O’Rourke K, Duan H, Poirier GG, Dixit VM (1996b) Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 271: 45734576
Chittenden T, Harrington EA, O’Connor R et al. (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733–736
Chiu VK, Walsh CM, Liu CC, Reed JC, Clark WR (1995) Bel-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. J Immunol 154: 2023–2032
Choi SS, Park IC, Yun JW, Sung YC, Hong SI, Shin HS (1995) A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693–1698
Clarke PG, Clarke S (1996) Nineteenth century research on naturally occurring cell death and related phenomena. Anat Embryol (Berl) 193: 81–99
Combadiere B, Reis e Sousa C, Trageser C, Zheng LX, Kim CR, Lenardo MJ (1998) Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. Immunity 9: 305–313
Conradt B, Horvitz HR (1998) The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93: 519–529
Cory S (1995) Regulation of lymphocyte survival by the bcl2 gene family. Annu Rev Immunol 13: 513–543
Croall DE, DeMartino GN (1991) Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev 71: 813–847
Deas 0, Dumont C, MacFarlane M et al. (1998) Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J Immunol 161: 3375–3383
Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH (1994) High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83: 3101–3103
Decoster E, Vanhaesebroeck B, Vandenabeele P, Grooten J, Fiers W (1995) Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem 270: 18473–18478
Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG (1997a) The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7: 813–820
Degli-Esposti MA, Smolak PJ, Walczak H et al. (1997b) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186: 1165–1170
Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A (1996) Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 15: 3861–3870
Dembic Z, Loetscher H, Gubler U et al. (1990) Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2: 231–237
Deveraux QL, Reed JC (1999) IAP family proteins–suppressors of apoptosis. Genes Dev 13: 239–252
Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH (1992) Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149: 3166–3173
Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373: 438–441
Dierlamm J, Baens M, Wlodarska I et al. (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6 associated with mucosa-associated lymphoid tissue lymphomas. Blood 93: 3601–3609
Drenou B, Blancheteau V, Burgess DH, Fauchet R, Charron DJ, Mooney NA (1999) A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J Immunol 163: 4115–4124
D’Souza SD, Bonetti B, Balasingam V et al. (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184: 2361–2370
Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33–42
Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He WW, Dixit VM (1996 a) ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas-and tumor necrosis factor-induced apoptosis. J Biol Chem 271: 1621–1625
Duan H, Orth K, Chinnaiyan AM et al. (1996 b) ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 271:16 720–16 724
Dugès A (1835) Recherche sur l’osteologie et la myologie des batracien à leurs différens ages. Mémoires présentés par divers savans à l’Academie royale de Science de l’Ínstitut de France, Science Mathématiques et Physiques 6: 1
Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H (1992) Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin’s disease. Cell 68: 421–427
Eberstadt M, Huang B, Chen Z et al. (1998) NMR structure and mutagenesis of the FADD ( Morti) death-effector domain. Nature 392: 941–945
Eby MT, Jasmin A, Kumar A, Sharma K, Chaudhary PM (2000) TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death. J Biol Chem 275:15. 336–15. 342
Eichhorst ST, Muller M, Li-Weber M, Schulze-Bergkamen H, Angel P, Krammer PH (2000) A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol 20: 7826–7837
Ellis HM, Horvitz HR (1986) Genetic control of programmed cell death in the nematode C. elegans. Cell 44: 817–829
Faubion WA, Guicciardi ME, Miyoshi H et al. (1999) Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103: 137–145
Faucheu C, Diu A, Chan AW et al. (1995) A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 14: 1914–1922
Faucheu C, Blanchet AM, Collard-Dutilleul V, Lalanne JL, Diu-Hercend A (1996) Identification of a cysteine protease closely related to interleukin-1 beta-converting enzyme. Eur J Biochem 236: 207–213
Fernandes-Alnemri T, Litwack G, Alnemri ES (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269:30. 761–30. 764
Fernandes-Alnemri T, Litwack G, Alnemri ES (1995a) Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res 55: 2737–2742
Fernandes-Alnemri T, Takahashi A, Armstrong R et al. (1995b) Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 55: 6045–6052
Fernandes-Alnemri T, Armstrong RC, Krebs J et al. (1996) In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADDlike domains. Proc Natl Acad Sci USA 93: 7464–7469
Fisher GH, Rosenberg FJ, Straus SE et al. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935–946
Flemming W (1885) Über die Bildung von Richtungfiguren in Säugetiereiern beim Untergang Graaf’scher Follikel. Arch Anat Physiol 1885: 221
Froelich CJ, Dixit VM, Yang X (1998) Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunol Today 19: 30–36
Galle PR, Hofmann WJ, Walczak H et al. (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182: 1223–1230
Gauchat JF, Mazzei G, Life P et al. (1994) Human CD40 ligand: molecular cloning, cellular distribution and regulation of IgE synthesis. Res Immunol 145: 240–249
Gervais FG, Xu D, Robertson GS et al. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloidbeta precursor protein and amyloidogenic A beta peptide formation. Cell 97: 395–406
Gibson L, Holmgreen SP, Huang DC et al. (1996) bd-w, a novel member of the bd-2 family, promotes cell survival. Oncogene 13: 665–675
Gibson SB, Oyer R, Spalding AC, Anderson SM, Johnson GL (2000) Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol Cell Biol 20: 205–212
Gillet G, Guerin M, Trembleau A, Brun G (1995) A Bcl-2-related gene is activated in avian cells transformed by the Rous sarcoma virus. EMBO J 14: 1372–1381
Godfrey WR, Fagnoni FF, Harara MA, Buck D, Engleman EG (1994) Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J Exp Med 180: 757–762
Goldin RD, Hunt NC, Clark J, Wickramasinghe SN (1993) Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes. J Pathol 171: 73–76
Goodwin RG, Alderson MR, Smith CA et al. (1993a) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73: 447–456
Goodwin RG, Din WS, Davis-Smith T et al. (1993b) Molecular cloning of a ligand for the inducible T cell gene 41BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol 23: 2631–2641
Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA (1992) Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 22: 3191–3194
Gray PW, Aggarwal BB, Benton CV et al. (1984) Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 312: 721–724
Green DR, Amarante-Mendes GP (1998) The point of no return: mitochondria, caspases, and the commitment to cell death. Res Probl Cell Diff 24: 45–61
Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189–1192
Hahne M, Rimoldi D, Schroter M et al. (1996) Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363–1366
Hahne M, Kataoka T, Schroter M et al. (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188: 1185–1190
Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L, Williams LT (1998) CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr Biol 8: 537–540
Haller A (1758) Sur la formation du coeur dans le poulet. Bousquet, Lausanne
Han J, Sabbatini P, White E (1996) Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol Cell Biol 16: 5857–5864
Harrop JA, McDonnell PC, Brigham-Burke M et al. (1998) Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 273:27. 54827. 556
Harvey W (1628) Exercitatio anatomica de motu cordis et sanguinis in animalibus. Sumptibus Gulielmi Fitzeri, Francoforti
Hegde R, Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES (1998) Blk, a BH3-containing mouse protein that interacts with Bd-2 and Bcl-xL, is a potent death agonist. J Biol Chem 273: 7783–7786
Hengartner MO, Horvitz HR (1994) Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bd-2. Nature 369: 318–320
Higaki K, Yano H, Kojiro M (1996) Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol 149: 429–437
Hildeman DA, Mitchell T, Teague TK et al. (1999) Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735–744
Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB (1999a) Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 285: 898–900
Hill LL, Shreedhar VK, Kripke ML, Owen-Schaub LB (1999b) A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation. J Exp Med 189: 1285–1294
Hockenberry MJ, Coody DK, Bennett BS (1990) Childhood cancers: incidence, etiology, diagnosis, and treatment. Pediatr Nurs 16: 239–246
Hollenbaugh D, Grosmaire LS, Kullas CD et al. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11: 4313–4321
Horvitz HR, Shaham S, Hengartner MO (1994) The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol 59: 377385
Hsu SY, Kaipia A, McGee E, Lomeli M, Hsueh AJ (1997a) Bok is a pro-apoptotic Bd-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bd-2 family members. Proc Natl Acad Sci USA 94:12. 401–12. 406
Hsu H, Solovyev I, Colombero A, Elliott R, Kelley M, Boyle WJ (1997b) ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem 272:13. 471–13. 474
Hsu SY, Lin P, Hsueh AJ (1998) BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bd-2 protein capable of dimerization with diverse antiapoptotic Bd-2 members. Mol Endocrinol 12: 1432–1440
Hu S, Snipas SJ, Vincenz C, Salvesen G, Dixit VM (1998) Caspase-14 is a novel developmentally regulated protease. J Biol Chem 273:29. 648–29. 653
Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik SW (1996) NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 384: 638–641
Huang DC, Cory S, Strasser A (1997a) Bd-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14: 405–414
Huang QR, Morris D, Manolios N (1997b) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol 34: 577–582
Hug H, Strand S, Grambihler A et al. (1997) Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 272:28. 191–28. 193
Humke EW, Ni J, Dixit VM (1998) ERICE, a novel FLICE-activatable caspase. J Biol Chem 273:15. 702–15. 707
Igney FH, Behrens CK, Krammer PH (2000) Tumor counter- attack-concept and reality. Eur J Immunol 30: 725–731
Imaizumi K, Tsuda M, Imai Y, Wanaka A, Takagi T, Tohyama M (1997) Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death. J Biol Chem 272:18. 842–18. 848
Inohara N, Ding L, Chen S, Nunez G (1997) Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bd-2 and Bcl-X(L). EMBO J 16: 16861694
Inohara N, Ekhterae D, Garcia I et al. (1998a) Mtd, a novel Bd-2 family member activates apoptosis in the absence of heterodimerization with Bd-2 and Bcl-XL. J Biol Chem 273: 8705–8710
Inohara N, Gourley TS, Carrio R et al. (1998b) Diva, a Bd-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death. J Biol Chem 273:32. 47932. 486
Irmler M, Thome M, Hahne M et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190195
Ito Y, Takeda T, Umeshita K et al. (1998) Fas antigen expression in hepatocellular carcinoma tissues. Oncol Rep 5: 4144
Itoh N, Nagata S (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268:10. 932–10. 937
Itoh N, Yonehara S, Ishii A et al. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233–243
Itoh N, Tsujimoto Y, Nagata S (1993) Effect of bd-2 on Fas antigen-mediated cell death. J Immunol 151: 621–627
Jaattela M, Benedict M, Tewari M, Shayman JA, Dixit VM (1995) Bd-x and Bd-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10: 2297–2305
Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC (1993) Bd-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365–369
Javitt NB (1966) Cholestasis in rats induced by taurolithocholate. Nature 210: 1262–1263
Jeong EJ, Bang S, Lee TH, Park YI, Sim WS, Kim KS (1999) The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD. J Biol Chem 274:16. 337–16. 342
Jo M, Kim TH, Seol DW et al. (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6: 564–567
Kamens J, Paskind M, Hugunin M et al. (1995) Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem 270:15. 250–15. 256
Karsan A, Yee E, Kaushansky K, Harlan JM (1996) Cloning of human Bd-2 homologue: inflammatory cytokines induce human Al in cultured endothelial cells. Blood 87: 3089–3096
Kasof GM, Gomes BC (2001) Livin, a novel inhibitor-of-apop- tosis ( IAP) family member. J Biol Chem 276: 3238–3246
Kato J, Kobune M, Kohgo Yet al. (1996) Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. J Clin Invest 98: 923–929
Kayagaki N, Kawasaki A, Ebata T et al. (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182: 1777–1783
Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257
Kischkel FC, Hellbardt S, Behrmann I et al. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex ( DISC) with the receptor. EMBO J 14: 5579–5588
Kitson J, Raven T, Jiang YP et al. (1996) A death-domaincontaining receptor that mediates apoptosis. Nature 384: 372–375
Klaus SJ, Sidorenko SP, Clark EA (1996) CD45 ligation induces programmed cell death in T and B lymphocytes. J Immunol 156: 2743–2753
Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997a) The release of cytochrome c from mitochondria: a primary site for Bd-2 regulation of apoptosis. Science 275: 1132–1136
Kluck RM, Martin SJ, Hoffman BM, Zhou JS, Green DR, Newmeyer DD (1997b) Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J 16: 4639–4649
Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S (1997) Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3: 409–413
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bd-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondria) membranes. Cancer Res 53: 4701–4714
Kroemer G (1997) The proto-oncogene Bc1–2 and its role in regulating apoptosis [published erratum appears in Nat Med 1997 Aug,3(8):934]. Nat Med 3: 614–620
Kroemer G (1998) The mitochondrion as an integrator/coordinator of cell death pathways. Cell Death Differ 5:547 Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6: 513–519
Kroemer G, Dallaporta B, Resche-Rigon M (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619–642
Kuida K, Zheng TS, Na S et al. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368–372
Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA (1994) Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev 8: 1613–1626
Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ (1997) Hepatocytes in the bile duct-ligated rat express Bd-2. Am J Physiol 272: G1587 - G1593
Kurose I, Higuchi H, Kato S, Miura S, Ishii H (1996) Ethanol-induced oxidative stress in the liver. Alcohol Clin Exp Res 20: 77A - 85A
Kurose I, Higuchi H, Miura S et al. (1997) Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 25: 368–78
Kwon BS, Weissman SM (1989) cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci USA 86: 1963 1967
Kwon BS, Tan KB, Ni J et al. (1997) A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 272:14. 272–14. 276
Kwon B, Yu KY, Ni J et al. (1999) Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J Biol Chem 274: 6056–61
Lacey DL, Timms E, Tan HL et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165–176
Lee RK, Spielman J, Podack ER (1996) Bd-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. Int Immunol 8: 991–1000
Leithauser F, Dhein J, Mechtersheimer G et al. (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69: 415–429
Leverkus M, Yaar M, Gilchrest BA (1997) Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 232: 255–262
Lippke JA, Gu Y, Sarnecki C, Caron PR, Su MS (1996) Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J Biol Chem 271: 1825–1828
Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF (2000) A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407: 642–645
Liston P, Roy N, Tamai K et al. (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349–353
Liu ZG, Baskaran R, Lea-Chou ET et al. (1996) Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384: 273–276
Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175–184
Liu X, Zou H, Widlak P, Garrard W, Wang X (1999) Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1. J Biol Chem 274:13. 836–13. 840
Loetscher H, Pan YC, Lahm HW et al. (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61: 351–359
Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bc12 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481–490
MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES (1997) Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 272:25. 417–25. 420
Madry C, Laabi Y, Callebaut I et al. (1998) The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily. Int Immunol 10: 1693–1702
Malinin NL, Boldin MP, Kovalenko AV, Wallach D (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385: 540–544
Mallett S, Fossum S, Barclay AN (1990) Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes–a molecule related to nerve growth factor receptor. EMBO J 9: 1063–1068
Mandal M, Maggirwar SB, Sharma N, Kaufmann SH, Sun SC, Kumar R (1996) Bd-2 prevents CD95 (Fas/APO-1)induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-kappaB signaling pathway. J Biol Chem 271:30. 354–30. 359
Mariani SM, Matiba B, Armandola EA, Krammer PH (1994) The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/Ipr mice. Eur J Immunol 24: 3119–3123
Mariani SM, Matiba B, Baumler C, Krammer PH (1995) Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25: 2303–2307
Marsters SA, Sheridan JP, Donahue CJ et al. (1996) Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol 6: 1669–1676
Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A (1998) Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol 8: 525–528
Marzo I, Brenner C, Kroemer G (1998a) The central role of the mitochondrial megachannel in apoptosis: evidence obtained with intact cells, isolated mitochondria, and purified protein complexes. Biomed Pharmacother 52: 248–251
Marzo I, Brenner C, Zamzami N et al. (1998b) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281: 2027–2031
Matsuzawa A, Moriyama T, Kaneko T et al. (1990) A new allele of the 1pr locus, 1prcg, that complements the gld gene in induction of lymphadenopathy in the mouse. J Exp Med 171: 519–531
Mauri DN, Ebner R, Montgomery RI et al. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8: 21–30
Medema JP, Toes RE, Scaffidi C et al. (1997) Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur J Immunol 27: 34923498
Memon SA, Moreno MB, Petrak D, Zacharchuk CM (1995) Bd-2 blocks glucocorticoid–but not Fas–or activation-induced apoptosis in a T cell hybridoma. J Immunol 155: 4644–4652
Minn AJ, Velez P, Schendel SL et al. (1997) Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 385: 353–357
Minn AJ, Kettlun CS, Liang H et al. (1999) Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J 18: 632–643
Mittl PR, Di Marco S, Krebs JF et al. (1997) Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J Biol Chem 272: 6539–6547
Monaghan P, Robertson D, Amos TA, Dyer MJ, Mason DW, Greaves MF (1992) Ultrastructural localization of bc1–2 protein. J Histochem Cytochem 40: 1819–1825
Mongkolsapaya J, Cowper AE, Xu XN et al. (1998) Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. J Immunol 160: 3–6
Montgomery RI, Warner MS, Lum BJ, Spear PG (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427–436
Muchmore SW, Sattler M, Liang H et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335–341
Mukhopadhyay A, Ni J, Zhai Y, Yu GL, Aggarwal BB (1999) Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem 274:15 978–15 981
Muller M, Wilder S, Bannasch D et al. (1998) p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 188: 2033–2045
Munday NA, Vaillancourt JP, Ali A et al. (1995) Molecular cloning and pro-apoptotic activity of ICEreiII and ICErelI1I, members of the ICE/CED-3 family of cysteine pro-teases. J Biol Chem 270:15. 870–15. 876
Muzio M, Chinnaiyan AM, Kischkel FC et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817–827
Nakagawa T, Yuan J (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150: 887–894
Nicholson DW, Ali A, Thornberry NA et al. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37–43
Nishimatsu H, Takeuchi T, Ueki T et al. (1999) CD95 ligand expression enhances growth of murine renal cell carcinoma in vivo. Cancer Immunol Immunother 48: 56–61
Nocentini G, Giunchi L, Ronchetti S et al. (1997) A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 94: 6216–6221
Oberhammer FA, Pavelka M, Sharma S et al. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA 89: 5408–5412
O’Connell J, O’Sullivan GC, Collins JK, Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184: 1075–1082
O’Connor L, Strasser A, O’Reilly LA et al. (1998) Bim: a novel member of the Bd-2 family that promotes apoptosis. EMBO J 17: 384–395
Oda E, Ohki R, Murasawa H et al. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053–1058
Oehm A, Behrmann I, Falk W et al. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267: 10709–10715
Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609–619
Ona VO, Li M, Vonsattel JP et al. (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington’s disease. Nature 399: 263–267
Osmond DG (1993) The turnover of B-cell populations [published erratum appears in Immunol Today 1993 Feb; 14(2):68]. Immunol Today 14: 34–37
Pan G, O’Rourke K, Chinnaiyan AM et al. (1997) The recep- tor for the cytotoxic ligand TRAIL. Science 276: 111–113
Pan G, Bauer JH, Haridas V et al. (1998) Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 431: 351–356
Parker MW, Pattus F (1993) Rendering a membrane protein soluble in water: a common packing motif in bacterial protein toxins. Trends Biochem Sci 18: 391–395
Peitsch MC, Tschopp J (1995) Comparative molecular modelling of the Fas-ligand and other members of the TNF family. Mol Immunol 32: 761–772
Pennica D, Nedwin GE, Hayflick JS et al. (1984) Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312: 724–729
Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M (1990) A nonsecretable cell surface mutant of tumor necrosis factor ( TNF) kills by cell-to-cell contact. Cell 63: 251–258
Peter ME, Krammer PH (1998) Mechanisms of CD95 (APO1/Fas)-mediated apoptosis. Curr Opin Immunol 10: 545551
Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH (1997) Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 27: 1207–1212
Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G (1996) Mitochondria and programmed cell death: back to the future. FEBS Lett 396: 7–13
Pettersen RD, Hestdal K, Olafsen MK, Lie SO, Lindberg FP (1999) CD47 signals T cell death. J Immunol 162: 70317040
Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687–12690
Podack ER (1989) Granule-mediated cytolysis of target cells. Curr Top Microbiol Immunol 140: 1–9
Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de The H (1998) PML induces a novel caspase-independent death process. Nat Genet 20: 259–265
Radeke MJ, Feinstein SC (1991) Analytical purification of the slow, high affinity NGF receptor: identification of a novel 135 kd polypeptide. Neuron 7: 141–150
Rajcan-Separovic E, Liston P, Lefebvre C, Korneluk RG (1996) Assignment of human inhibitor of apoptosis protein (IAP) genes xiap, hiap-1, and hiap-2 to chromosomes Xq25 and 11q22-q23 by fluorescence in situ hybridization. Genomics 37: 404–406
Rasper DM, Vaillancourt JP, Hadano S et al. (1998) Cell death attenuation by “Usurpin”, a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ 5: 271–288
Rathke H (1825) Kiemen bey Säugethieren. Isis 747
Ray RB, Meyer K, Ray R (1996) Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226: 176–182
Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK (1998) Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8: 615–623
Reynolds JE, Yang T, Qian L et al. (1994) Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 54: 6348–6352
Rieux-Laucat F, Le Deist F, Hivroz C et al. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347–1349
Roberts LR, Kurosawa H, Bronk SF et al. (1997) Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 113: 1714–1726
Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243–1252
Rotonda J, Nicholson DW, Fazil KM et al. (1996) The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat Struct Biol 3: 619–625
Rouvier E, Luciani MF, Golstein P (1993) Fas involvement in Ca(2)-independent T cell-mediated cytotoxicity. J Exp Med 177: 195–200
Roy N, Mahadevan MS, McLean M et al. (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167178
Ruggieri A, Harada T, Matsuura Y, Miyamura T (1997) Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229: 68–76
Rust C, Karnitz LM, Paya CV, Moscat J, Simari RD, Gores GJ (2000) The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 275: 20210–20216
Sakahira H, Enari M, Nagata S (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96–99
Scaffidi C, Fulda S, Srinivasan A et al. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675–1687
Scaffidi C, Kirchhoff S, Krammer PH, Peter ME (1999 a) Apoptosis signaling in lymphocytes. Curr Opin Immunol 11: 277–285
Scaffidi C, Schmitz I, Krammer PH, Peter ME (1999b) The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274: 1541–1548
Schall TJ, Lewis M, Koller KJ et al. (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61: 361–370
Schendel SL, Xie Z, Montal MO, Matsuyama S, Montal M, Reed JC (1997) Channel formation by antiapoptotic protein Bd-2. Proc Natl Acad Sci USA 94: 5113–5118
Schilsky ML (1997) Ironic insult added to copper injury. Hepatology 25: 776–778
Schleiden MJ (1842) Grundzuege der wissenschaftlichen Botanik. Engelmann, Leipzig
Schmucker DL, Ohta M, Kanai S, Sato Y, Kitani K (1990) Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 12: 1216–1221
Schneider P, Bodmer JL, Thome M, Hofmann K, Holler N, Tschopp J (1997) Characterization of two receptors for TRAIL. FEBS Lett 416: 329–334
Schneider P, MacKay F, Steiner V et al. (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189: 1747–1756
Schulte-Hermann R, Bursch W, Grasl-Kraupp B (1995a) Active cell death (apoptosis) in liver biology and disease. Prog Liver Dis 13: 1–35
Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Torok L, El-linger A, Mullauer L (1995b) Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol Lett 82–83: 143–148
Schwann T (1839) Mikroskopische Untersuchungen ueber die Uebereinstimmung in der Struktur and dem Wachstum der Tiere and Pflanzen. Sander, Berlin
Screaton GR, Mongkolsapaya J, Xu XN, Cowper AE, McMichael AJ, Bell JI (1997 a) TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr Biol 7: 693–696
Screaton GR, Xu XN, Olsen AL et al. (1997b) LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA 94: 4615–4619
Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) bc1–2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879–888
Sheridan JP, Marsters SA, Pitti RM et al. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818–821
Shi YF, Szalay MG, Paskar Let al. (1990) Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation [published erratum appears in J Immunol 1990 Dec 1; 145(11):39451 J Immunol 144: 3326–3333
Shimizu M, Yoshimoto T, Nagata S, Matsuzawa A (1996) A trial to kill tumor cells through Fas (CD95)-mediated apoptosis in vivo. Biochem Biophys Res Commun 228: 375–379
Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB (1985) Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature 313: 803–806
Shu HB, Hu WH, Johnson H (1999) TALL-1 is a novel member of the TNF family that is down-regulated by mito-gens. J Leukoc Biol 65: 680–683
Siegel RM, Frederiksen JK, Zacharias DA et al. (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288: 2354–2357
Simonet WS, Lacey DL, Dunstan CR et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309–319
Singer GG, Abbas AK (1994) The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1: 365–371
Smith CA, Davis T, Anderson D et al. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019–1023
Smith CA, Gruss HJ, Davis T et al. (1993) CD30 antigen, a marker for Hodgkin’s lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73: 1349–1360
Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959–962
Smyth MJ, Thia KY, Cretney E et al. (1999) Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol 162: 6658–6662
Song Q, Kuang Y, Dixit VM, Vincenz C (1999) Boo, a novel negative regulator of cell death, interacts with Apaf-1. EMBO J 18: 167–178
Spengler U, Zachoval R, Gallati H et al. (1996) Serum levels and in situ expression of TNF-alpha and TNF-alpha binding proteins in inflammatory liver diseases. Cytokine 8: 864–872
Srinivasula SM, Fernandes-Alnemri T, Zangrilli J et al. (1996) The Ced-3/interleukin lbeta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J Biol Chem 271: 27099–27106
Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES (1998a) Autoactivation of procaspase-9 by Apaf-1mediated oligomerization. Mol Cell 1: 949–957
Srinivasula SM, Ahmad M, MacFarlane M et al. (1998b) Generation of constitutively active recombinant caspases3 and -6 by rearrangement of their subunits. J Biol Chem 273: 10107–10111
Stamenkovic I, Clark EA, Seed B (1989) A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8: 1403–1410
Strand S, Hofmann WJ, Hug H et al. (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells–a mechanism of immune evasion? Nat Med 2: 1361–1366
Strand S, Hofmann WJ, Grambihler A et al. (1998) Hepatic failure and liver cell damage in acute Wilson’s disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 4: 588–593
Strasser A, Harris AW, Huang DC, Krammer PH, Cory S (1995) Bc1–2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14: 6136–6147
Streffer JR, Schuster M, Pohl U et al. (1999) Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions. Anticancer Res 19: 5265–5269
Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA (1997) CD95 ligand ( FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99: 396402
Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 11691178
Susin SA, Zamzami N, Castedo M et al. (1996) Bd-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184: 1331–1341
Susin SA, Lorenzo HK, Zamzami N et al. (1999a) Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 189: 381–394
Susin SA, Lorenzo HK, Zamzami N et al. (1999b) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441–416
Susin SA, Daugas E, Ravagnan L et al. (2000) Two distinct pathways leading to nuclear apoptosis. J Exp Med 192: 571–580
Sytwu HK, Liblau RS, McDevitt HO (1996) The roles of Fas/ APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5: 17–30
Takahashi T, Tanaka M, Brannan CI et al. (1994a) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969–976
Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S (1994b) Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 6: 1567–1574
Takayama S, Sato T, Krajewski S et al. (1995) Cloning and functional analysis of BAG-1: a novel Bc1–2-binding protein with anti-cell death activity. Cell 80: 279–284
Takeuchi T, Ueki T, Nishimatsu H et al. (1999) Accelerated rejection of Fas ligand-expressing heart grafts. J Immunol 162: 518–522
Takimoto R, El-Deiry WS (2000) Wild-type p53 trans-activates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 19: 17351743
Tanaka S, Saito K, Reed JC (1993) Structure-function analysis of the Bd-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bd-2 beta protein restores function as a regulator of cell survival. J Biol Chem 268: 10920–10926
Tanaka M, Suda T, Takahashi T, Nagata S (1995) Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 14: 1129–1135
Tartaglia LA, Ayres TM, Wong GH, Goeddel DV (1993 a) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845–853
Tartaglia LA, Pennica D, Goeddel DV (1993 b) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18. 542–18. 548
Tewari M, Quan LT, O’Rourke K et al. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADPribose) polymerase. Cell 81: 801–809
Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1462
Thornberry NA, Bull HG, Calaycay JR et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768–774
Trapani JA, Jans P, Smyth MJ et al. (1998) Perforin-dependent nuclear entry of granzyme B procedes apoptosis, and is not a consequence of nuclear membrane dysfunction. Cell Death Differ 5: 488–496
Trauth BC, Klas C, Peters AM et al. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301–305
Tsujimoto Y, Cossman J, Jaffe E, Croce CM (1985a) Involvement of the bc1–2 gene in human follicular lymphoma. Science 228: 1440–1443
Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM (1985b) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390–1393
Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM (1985c) Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 315: 340–343
Van de Craen M, Vandenabeele P, Declercq W et al. (1997) Characterization of seven murine caspase family members. FEBS Lett 403: 61–69
Van de Craen M, Van Loo G, Pype S et al. (1998) Identification of a new caspase homologue: caspase-14. Cell Death Differ 5: 838–846
Van der Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627–637
Van Parijs L, Ibraghimov A, Abbas AK (1996) The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4: 321–328
Varfolomeev EE, Schuchmann M, Luria V et al. (1998) Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apol, and DR3 and is lethal prenatally. Immunity 9: 267–276
Vaux DL, Korsmeyer SJ (1999) Cell death in development. Cell 96: 245–254
Vaux DL, Cory S, Adams JM (1988) Bc1–2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440–442
Verhagen AM, Ekert PG, Pakusch M et al. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43–53
Vincenz C, Dixit VM (1997) Fas-associated death domain protein interleukin-lbeta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J Biol Chem 272: 6578–6583
Vogt C (1842) Untersuchungen ueber die Entwicklung der Geburtshelferkroete (Alytes obstetricans). Jent & Gass-mann, Solothurn
Walczak H, Degli-Esposti MA, Johnson RS et al. (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 16: 5386–5397
Walczak H, Miller RE, Ariail K et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157–163
Walczak H, Bouchon A, Stahl H, Krammer PH (2000) Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bd-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Res 60: 3051–3057
Walker NP, Talanian RV, Brady KD et al. (1994) Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell 78: 343352
Wang HG, Reed JC (1998) Mechanisms of Bd-2 protein function. Histol Histopathol 13: 521–530
Wang AM, Creasey AA, Ladner MB et al. (1985) Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228: 149–154
Wang L, Miura M, Bergeron L, Zhu H, Yuan J (1994) Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739–750
Wang S, Miura M, Jung Y et al. (1996a) Identification and characterization of Ich-3, a member of the interleukinlbeta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J Biol Chem 271:20. 580–20. 587
Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ (1996b) BID: a novel BH3 domain-only death agonist. Genes Dev 10: 2859–2869
Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992 a) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314–317
Watanabe-Fukunaga R, Brannan CI, Itoh N et al. (1992 b) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274–1279
Weissmann A (1863) Die Entwicklung der Dipterien im Ei nach Beobachtung an Chironomus spec. Z Wiss Zool 14: 187
Westendorp MO, Frank R, Ochsenbauer C et al. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497–500
Wiley SR, Schooley K, Smolak PJ et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673–682
Wilson KP, Black JA, Thomson JA et al. (1994) Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370: 270–275
Wong BR, Josien R, Lee SY et al. (1997) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186: 2075–2080
Yang Y, Ashwell JD (1999) Thymocyte apoptosis. J Clin Immunol 19: 337–349
Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ (1995) Bad, a heterodimeric partner for Bcl-XL and Bd-2, displaces Bax and promotes cell death. Cell 80: 285–291
Yang J, Liu X, Bhalla K et al. (1997) Prevention of apoptosis by Bd-2: release of cytochrome c from mitochondria blocked. Science 275: 1129–1132
Yasuda H, Shima N, Nakagawa N et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597–3602
Yin XM, Wang K, Gross A et al. (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886–891
Yonehara S, Ishii A, Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747–1756
Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS (1999) A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 274:13 733–13 736
Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75: 641–652
Zamzami N, Marchetti P, Castedo M et al. (1995) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 181: 1661–1672
Zamzami N, Marchetti P, Castedo M et al. (1996 a) Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 384: 53–57
Zamzami N, Susin SA, Marchetti P et al. (1996b) Mitochondrial control of nuclear apoptosis. J Exp Med 183: 15331544
Zamzami N, Brenner C, Marzo I, Susin SA, Kroemer G (1998 a) Subcellular and submitochondrial mode of action of Bc1–2-like oncoproteins. Oncogene 16: 2265–2282
Zamzami N, Marzo I, Susin SA et al. (1998b) The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bd-2 by enforcing mitochondrial permeability transition. Oncogene 16: 1055–1063
Zhao M, Laissue JA, Zimmermann A (1997) Hepatocyte apoptosis in hepatic iron overload diseases. Histol Histopathol 12: 367–374
Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405–413
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Eichhorst, S.T., Krammer, P.H. (2003). Apoptose. In: Ganten, D., Ruckpaul, K. (eds) Grundlagen der Molekularen Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07588-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-07588-3_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-07589-0
Online ISBN: 978-3-662-07588-3
eBook Packages: Springer Book Archive